U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT06798805) titled 'Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms' on Dec. 30, 2024.
Brief Summary: In this study the aim is to investigate the pathogenetic role of extracellular vesicles and senescence in Myeloproliferative Neoplasms. In particular, the goal of this project is to identify possible EV-based biomarkers of senescence according to gender, which are disease-specific, biology-related, and predictive of short-term outcome in terms of Event-Free Survival and to define personalized targets for new therapeutic approaches.
Study Start Date: Feb. 15, 2022
Study Type: OBSERVATIONAL
Condition:
E...